Switching REMS Vendors: AAM Calls For FDA Guidance On Performance Standards

Risk mitigation
The FDA gets advice on dealing with changes in vendors administering Risk Evaluation and Mitigation Strategies. • Source: Shutterstock

More from Drug Safety

More from Pink Sheet